聯眾(06899.HK)向公司一股東及兩名前董事提出法律訴訟
聯眾(06899.HK)公布,於9月16日,公司作為原告在高等法院原訟法庭分別向亮智控股有限公司、前董事傅強及高宏提起民事訴訟,要求其償還以快通貿易有限公司及或Merit Horizon Limited之名義所簽署的貸款協議項下未償還之本金及相應的利息,並向法院申請永久禁制令禁止亮智違反其關於行使股東權利的承諾,同時 ,針對兩人違反作為前董事授信責任兼提出索賠。
聯眾指,亮智持有公司已發行股本約27.08% , 且為體育之窗的間接全資附屬,而傅強為體育之窗的股東及董事長,高宏則為體育之窗的股東及董事。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.